Researchers from the University of Aberdeen trying new approach where the patient is more involved in decision-making around ...

Not only does it provide superior effectiveness results compared with tolterodine IR, it also leads to lower overall costs. Over the course of 1 year, overall costs are £418 per patient with ...

Objective: This double-blind, multinational study was performed to further evaluate the efficacy of tolterodine, a newbladder-selective antimuscarinic agent, for reducing urge incontinence ...